Medical News

RSS
Broken health system aggravates cholera outbreak in Zimbabwe

Broken health system aggravates cholera outbreak in Zimbabwe

Xencor presents data on anti-CD19 and anti-CD40 antibodies

Xencor presents data on anti-CD19 and anti-CD40 antibodies

Major math anxiety in stressful situations

Major math anxiety in stressful situations

VIDAZA (azacitidine) study reports survival benefit in higher-risk MDS extends to AML patients

VIDAZA (azacitidine) study reports survival benefit in higher-risk MDS extends to AML patients

UK kidney cancer patients face toxic, out-dated treatments with little hope of change

UK kidney cancer patients face toxic, out-dated treatments with little hope of change

Study reveals effects of unconscious exposure to advertisements

Study reveals effects of unconscious exposure to advertisements

Pregnant women warned not to use statins

Pregnant women warned not to use statins

Siblings of mentally disabled face own lifelong challenges

Siblings of mentally disabled face own lifelong challenges

DNA vaccine for SARS achieves neutralizing responses in first U.S. human trial

DNA vaccine for SARS achieves neutralizing responses in first U.S. human trial

New clues to the roots of epilepsy, autism, schizophrenia

New clues to the roots of epilepsy, autism, schizophrenia

Reforms needed in adolescent health care

Reforms needed in adolescent health care

Quantros acquires MEDMARX from United States Pharmacopeia

Quantros acquires MEDMARX from United States Pharmacopeia

Discovery of gender gap in spatial skills that starts in infancy

Discovery of gender gap in spatial skills that starts in infancy

UK's first prostate cancer patient treated using RapidArc radiotherapy

UK's first prostate cancer patient treated using RapidArc radiotherapy

Experimental drug successfully blocks mutation in bone marrow cancers

Experimental drug successfully blocks mutation in bone marrow cancers

Advances in tissue engineering

Advances in tissue engineering

Potential breakthrough for T-cell lymphoma

Potential breakthrough for T-cell lymphoma

Portola Pharmaceuticals starts phase 2 trial of P2Y12 ADP receptor antagonist in non-urgent percutaneous coronary intervention

Portola Pharmaceuticals starts phase 2 trial of P2Y12 ADP receptor antagonist in non-urgent percutaneous coronary intervention

Pycnogenol reduces inflammatory marker C-reactive protein in osteoarthritis

Pycnogenol reduces inflammatory marker C-reactive protein in osteoarthritis

People who want access to the NHS should behave more responsibly, says expert

People who want access to the NHS should behave more responsibly, says expert

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.